- Q2 2024 Coloplast A/S Earnings Call TranscriptMay 07, 2024kr838.2 (-2.63%)Earnings
- Q1 2024 Coloplast A/S Earnings Call TranscriptFeb 09, 2024kr893.8 (+10.13%)Earnings
- Q4 2023 Coloplast A/S Earnings Call TranscriptNov 09, 2023kr717.5 (-6.79%)Earnings
- Coloplast A/S to Discuss Complete Acquisition of Kerecis Call TranscriptSep 04, 2023
- Q3 2023 Coloplast A/S Earnings Call TranscriptAug 17, 2023kr809 (-1.38%)Earnings
- Coloplast A/S Announces Agreement to Acquire Kerecis Call TranscriptJul 07, 2023
- Q2 2023 Coloplast A/S Earnings Call TranscriptMay 11, 2023kr928.6 (-4.98%)Earnings
- Q1 2023 Coloplast A/S Earnings Call TranscriptFeb 03, 2023kr842.7 (-1.53%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 01, 2022
- Q4 2022 Coloplast A/S Earnings Call TranscriptNov 07, 2022kr788.6 (-3.33%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 31, 2022
- Q3 2022 Coloplast A/S Earnings Call TranscriptAug 17, 2022kr879.5 (+5.10%)Earnings
- Q2 2022 Coloplast A/S Earnings Call TranscriptMay 05, 2022kr951.5 (-5.21%)Earnings
- Coloplast A/S Virtual ESG Event Call TranscriptMar 22, 2022
- Q1 2022 Coloplast A/S Earnings Call TranscriptJan 25, 2022kr947.9 (+1.02%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 02, 2021
- Coloplast A/S to Acquire Atos Medical Call TranscriptNov 08, 2021
- Q4 2021 Coloplast A/S Earnings Call TranscriptNov 01, 2021kr1024 (-2.89%)Earnings
- Q3 2021 Coloplast A/S Earnings Call TranscriptAug 18, 2021kr1106 (-3.39%)Earnings
- Q2 2021 Coloplast A/S Earnings Call TranscriptMay 06, 2021kr973.5 (-5.62%)Earnings
- Q1 2021 Coloplast A/S Earnings Call TranscriptFeb 02, 2021kr1020.3 (+9.15%)Earnings
- Coloplast A/S at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q4 2020 Coloplast A/S Earnings Call TranscriptNov 03, 2020kr917.2 (-2.13%)Earnings
- Coloplast A/S Virtual Sustainability Deep-Dive Session TranscriptOct 09, 2020
- Coloplast A/S Virtual Deep-Dive Sessions TranscriptOct 07, 2020
- Coloplast A/S Virtual Capital Markets Day TranscriptSep 29, 2020
- Q3 2020 Coloplast A/S Earnings Call TranscriptAug 18, 2020kr1000.75 (-3.03%)Earnings
- Coloplast A/S at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q2 2020 Coloplast A/S Earnings Call TranscriptMay 06, 2020kr1048.5 (-1.92%)Earnings
- Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call TranscriptMar 19, 2020
- Q1 2020 Coloplast A/S Earnings Call TranscriptFeb 06, 2020kr905.9 (+3.39%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 05, 2019
- Q4 2019 Coloplast A/S Earnings Call TranscriptNov 05, 2019kr794.4 (-3.39%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 20, 2019
- Q3 2019 Coloplast A/S Earnings Call TranscriptAug 14, 2019kr808.7 (+1.95%)Earnings
- Q2 2019 Coloplast A/S Earnings Call TranscriptMay 02, 2019kr702.2 (-2.01%)Earnings
Q3 2022 Coloplast A/S Earnings Call Transcript
Welcome to the Coloplast interim financial statements for 9M 2021, '22. (Operator Instructions)
With that, I'll hand the floor to our speakers. Please begin your meeting.
/-&
Good afternoon, and welcome to our Q3 '21/'22 Conference Call. My name Kristian Villumsen. I'm the CEO of Coloplast. And I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We'll start like we usually do with a short presentation by Anders and myself, and then open up for questions from you.
Please turn to Slide #3. In Q3, we delivered 8% organic growth and an EBIT margin before special items of 30%. We delivered a respectable return on invested capital of 26% after tax and before special items, impacted by the acquisition of Atos Medical. Reported growth in Danish kroner was 21%. Atos Medical contributed 9 percentage points to the reported growth and delivered double-digit underlying growth.
Before I dive into today's results, I'd
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)